- 9.3k views
Prolonged Fever: Thromboembolism, Guillain-Barre, Brucellosis
Explore the complexities of diagnosing prolonged, undiagnosed cases of fever through the Durak and Street classification system. Learn to recognize warning signals that indicate serious underlying conditions. Delve into the investigative process necessary for these challenging cases. This session presents two intriguing case studies. The first involves a woman with a 40-day history of fever, initially showing ECG findings suggestive of pulmonary thromboembolism (PTE), but ultimately diagnosed with Guillain-Barré syndrome, with further complications contributing to her prolonged fever. The second case explores a patient admitted with a 15-day fever, severe headache, body pain, and joint pain, leading to a final diagnosis of brucellosis after thorough investigation. Join us to gain a deeper understanding of the diagnostic challenges and treatment strategies for prolonged fever, enhancing your ability to manage such complex cases in clinical practice.
About the Speaker
Dr. Shubhangi Kamble
Consultant Ano rectal Surgeon, Aayush Hospital Dharavi, Mumbai
Upcoming Case Discussions
Latest Surgical Approaches to Oral Cancer
Recent advancements in surgical approaches to oral cancer have emphasized precision and minimally invasive techniques. Robotic-assisted surgery and transoral laser microsurgery allow for enhanced accuracy, reducing damage to surrounding tissues. Surgeons also increasingly use image-guided technology, which enhances visualization and helps remove tumors more effectively. Sentinel lymph node biopsy has become a standard for early-stage oral cancer, enabling better staging with minimal invasiveness. These advancements contribute to faster recovery times, reduced complications, and improved overall outcomes for patients.
Clinician’s Approach to Septic Shock
The prognosis of sepsis syndromes varies and spans a clinical spectrum. The most serious consequence of sepsis, septic shock, has a high death rate. An inciting substance triggers the activation of both the pro-inflammatory and anti-inflammatory immune systems, leading to septic shock. This takes place in tandem with the activation of neutrophils, monocytes, and macrophages, which engage with the endothelium via pathogen recognition receptors and cause further cytokine, protease, kinin, reactive oxygen species, and nitric oxide involvement. The endothelium is the main location of this reaction, and in addition to microvascular damage, it also triggers the complement and coagulation cascades, which worsen the vascular damage and cause capillary leakage. The clinical signs and symptoms of sepsis and the progression from sepsis are caused by this series of events.
Nutrition Strategies for good Glycemic Control
Effective nutrition strategies for good glycemic control include choosing low-glycemic foods that prevent rapid spikes in blood sugar, such as whole grains, legumes, and non-starchy vegetables. Balancing macronutrients, particularly with a focus on healthy fats and proteins, can help stabilize blood sugar. Portion control and consistent meal timing are also vital to avoid blood sugar fluctuations. Including fiber-rich foods supports slower glucose absorption, aiding in prolonged blood sugar control. Staying hydrated and limiting added sugars can further support overall glycemic stability.
AI Transforming Clinical Practice
The "quadruple aim" of healthcare—improving population health, improving patient and caregiver experiences, and lowering the rising cost of care—presents formidable obstacles for healthcare systems worldwide. Global healthcare expenditures, the burden of chronic diseases, and aging populations are making it harder for governments, payers, regulators, and providers to innovate and change healthcare delivery models. Furthermore, healthcare systems are forced to "perform" (provide efficient, high-quality care) and "transform" care at scale by incorporating real-world data-driven insights into patient care in the context of the current global pandemic.
CAR T Cells in Cancer Gene Therapy
CAR T-cell therapy is a groundbreaking approach in cancer gene therapy that harnesses a patient’s immune cells to target and destroy cancer cells. In this technique, T-cells are genetically modified to express chimeric antigen receptors (CARs) that specifically recognize cancer cells. Once reintroduced into the patient, these CAR T-cells seek out and eliminate cancer cells with high precision. This therapy has shown remarkable success in treating certain types of blood cancers, such as leukemia and lymphoma, and is being explored for solid tumors. CAR T-cell therapy offers a promising personalized treatment, with ongoing research aimed at enhancing its safety, effectiveness, and applicability to a wider range of cancers.